Jan 09, 2024 / 01:15AM GMT
Seiji Wakao - JPMorgan Chase & Co, Research Division - VP
Welcome to JPMorgan Healthcare Conference. I'm Seiji Wakao, Japan pharma analyst. We will conduct this session via fireside chat form. And James Gordon will lead the fireside chat. He's a European pharma analyst. And he and I will be covering Takeda.
And I'd like to introduce the speakers from Takeda: Christophe Weber, President and CEO; Andy Plump, President, R&D; and Costa Saroukos, CFO; Ramona Sequeira, President, Global Portfolio division; and Julie Kim, President, U.S. Business Unit.
Let me turn it over to James.
James Daniel Gordon - JPMorgan Chase & Co, Research Division - Senior Analyst
Good evening, everyone. I'm James Gordon. As mentioned, I'm a pharma analyst at JPMorgan. Along with Wakao, we both look at Takeda. And the plan for today is we're going to have a fireside chat. So I'm going to go for a couple of questions with the team. And then we both may have some further questions as well, and we'll leave time to take your questions from the audience.
Takeda Pharmaceutical Co Ltd at JPMorgan Healthcare Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot